Literature DB >> 12814733

Raynaud's disease.

J C R Bowling1, P M Dowd.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12814733     DOI： 10.1016/s0140-6736(03)13646-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Daily dosing of PDE5 inhibitors: where does it fit in?

Authors:  King Chien Joe Lee; Gerald B Brock
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

Review 2.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies.

Authors:  Rozeena Garner; Rakesh Kumari; Peter Lanyon; Michael Doherty; Weiya Zhang
Journal:  BMJ Open       Date:  2015-03-16       Impact factor: 2.692

Review 3.  Extrahepatic Manifestations of Primary Biliary Cholangitis.

Authors:  Sara L Chalifoux; Peter G Konyn; Gina Choi; Sammy Saab
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

4.  DSGOST regulates resistance via activation of autophagy in gastric cancer.

Authors:  Tae Woo Kim; Seon Young Lee; Mia Kim; Chunhoo Cheon; Bo-Hyoung Jang; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Cell Death Dis       Date:  2018-05-29       Impact factor: 8.469

5.  Raynaud's phenomenon manifesting as progressive abnormal MRI bone marrow signal in the toes.

Authors:  Mason A Brown; Douglas Handley; Andrew Simon
Journal:  Radiol Case Rep       Date:  2019-09-05

6.  Case Report: Artifactual Hypoglycemia: A Condition That Should Not Be Forgotten.

Authors:  Sara Amaral; Ana Palha; Vera Bernardino; José Silva-Nunes
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.